Cannabidiol (GWP42003-P, CBD)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Cannabidiol (GWP42003-P, CBD), covering 2018-07-27 to 2022-07-14. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) [Phase 3]